Biopharmaceutical
Pain
Usa
Development
Commercializing
Therapies
United
States
M&A Advisory
Lazard
Full Credential Description
NeurogesX. United States. Announced Date 02/05/2007. Closed Date 07/05/2007. Deal value: $44m. Initial public offering. Industry: NeurogesX is a biopharmaceutical company focused on developing and commercializing pain management therapies.